The leaders at Beaufort are highly skilled and educated professionals who provide successful project guidance time after time, and, therefore, many are esteemed as leaders in the greater industries we serve. Our management team has earned an exceptional reputation among the clients we’ve worked with worldwide. The value we cultivate is evident in the success of the projects we’ve supported and what our clients have to say about working with us. This is the management team that accelerates medical innovation.
CHAIRMAN AND CEO, COFOUNDER
As cofounder, chairman and CEO, Al has provided the overall leadership and guidance that formed Beaufort’s business strategy, value proposition and operating model. His more than 30 years of financial management and business experience includes senior management positions in large and small companies. He has been directly involved in building Beaufort’s team of highly motivated and talented professionals and provided the capital to establish the company and finance its early operations.
Before founding Beaufort, Al served in the following positions:
- Landmark Communications Inc. as executive vice president and chief financial officer
- Great Bridge LLC (a Landmark open-source software startup venture) as president and CEO
- TeleCable Corporation as executive vice president and chief financial officer
At both Landmark and TeleCable, Al worked within ethical, disciplined and strategically focused businesses. He held a leadership role in analyzing and selecting corporate investment opportunities, making acquisitions and dispositions, and in setting business strategies. He was responsible for the overall business performance of various subsidiaries and helped operating managers develop strategies to expand their business, start new businesses and improve operating results.
Al holds a bachelor’s degree in business administration from the College of William and Mary in Virginia. Early in his career, he was a certified public accountant and served as an officer in the U.S. Navy.
Clay joined Beaufort in 2010 and is responsible for leading Beaufort’s global operations. Through her leadership, passion and vision, Clay successfully manages multidisciplinary teams that deliver creative and effective solutions to complex and evolving business challenges. Her ability to deftly align sales, marketing and operations while keenly understanding a client’s individual needs is a critical factor in helping Beaufort consistently deliver program success for its clients.
With more than 20 years of experience across a variety of industries, Clay has consulted and guided numerous organizations in the design and implementation of customer-focused and dynamic business strategies. This focus on seamless integration and tangible results has been a trademark of her career.
Before joining Beaufort, Clay held the following positions:
- Dominion Enterprises with successive positions leading to senior vice president of corporate strategy and business development
- Kraft General Foods as an associate brand manager
- First Union National Bank as a commercial banking officer
Clay holds a bachelor’s degree in religious studies from Davidson College and a Master of Business Administration from Virginia’s Darden Graduate School of Business.
Executive Vice President, Business Development, Cofounder
Schuyler has worked in the health care industry since 1977. His extensive knowledge regarding the business and product development challenges facing Beaufort clients was a key factor in the company’s formation and in the development of the company’s business strategy and value proposition. As a cofounder and member of the company’s board of directors, he has been devoted to serving Beaufort clients since 2004. Schuyler is responsible for assessing and managing new business opportunities as well as fostering ongoing client relationships. He is also a senior member of the team that develops Beaufort’s marketing and related materials.
Before founding Beaufort, Schuyler held the following positions:
- Bio-Reg Associates Inc. as vice president of marketing and sales
- Olsten Health Services as regional operations manager
- Vanguard Laboratories Inc. as president
- Boehringer Ingelheim Pharmaceuticals Inc. as in-line and new products development manager
- Merck, Sharpe & Dohme Pharmaceuticals Inc. as in-line cardiovascular product manager
Schuyler holds a bachelor’s degree in marketing and management from Virginia Tech and a Master of Business Administration from the University of Georgia.
John R. Wilson Jr., Ph.D., MPH
Senior Vice President, Clinical Development and Quality Solutions
Dr. Wilson has worked in the health care industry his entire career and has broad-based experience in clinical research and pharmaceutical manufacturing, regulatory strategy and compliance, and quality management. He has overall management responsibility for Beaufort’s quality oversight and clinical trial monitoring practices. As a member of Beaufort’s senior management team, he also has a leadership role in identifying and developing high-quality, customized solutions to clients’ regulatory, clinical development, quality management and manufacturing needs. These activities include clinical development and study design, clinical trial management, inspection readiness, regulatory submissions and cGMP and cGCP support.
Prior to joining Beaufort, Dr. Wilson held the following positions:
- SociusRx LLC as CEO and founder
- Boehringer Ingelheim Corporation
- Chemicals Division as vice president of quality management, regulatory affairs and human resources
- Prescription Drug Division as director of medical administration and GCP regulatory compliance
- Prescription Drug Division as regional manager and clinical research associate
Dr. Wilson holds a bachelor’s degree in biological sciences from Centenary College of Louisiana, a master’s degree and a Ph.D. in health policy from Rice University and an MPH in health services management from Columbia University.
Trish Landry, MBA, RAC, CCRP
Senior Vice President, Clinical Operations
With more than 20 years’ experience navigating regulatory processes and managing clinical trials, Trish oversees all aspects of Beaufort’s clinical operations and helps clients implement clinical programs and regulatory affairs strategies. She coordinates domestic and international clinical trial programs, focusing on protocol development, data collection and management, CRA training and management, investigator selection, recruitment and training, site initiations, periodic monitoring and close-outs as well as clinical study report preparation. She also has extensive experience in the preparation of multiple U.S. regulatory submissions and has effectively led FDA GCP and QSR inspections.
Before joining Beaufort, Trish held the following positions at:
- The Weinberg Group, Inc. and M Squared Associates, Inc. as a senior level consultant and program manager
- The American Red Cross/Baxter Healthcare Corporation and Nova Pharmaceutical Corporation as a clinical research associate
Trish holds a bachelor’s degree in chemistry and microbiology from Bowling Green State University and a master’s degree in business from Loyola University Maryland’s Sellinger School of Business and Management. Additionally, she holds a Regulatory Affairs Certification and is a Certified Clinical Research Professional.
Karin Hughes, Ph.D.
Senior Vice President, Regulatory and Quality
Karin is a 20-year veteran of the in vitro diagnostic, biotech and life science industries with extensive experience in global regulatory strategy, quality system management and implementation, and clinical operations for a broad range of programs and products. Her diverse background spans early product development to market authorization and continued on-market expansion and support.
She provides Beaufort’s clients with value-added scientific and strategic solutions aimed at successful market authorization to accelerate diagnostic commercialization and assure total product life cycle compliance. This includes helping clients, from venture-capital funded to mid- and large-sized IVD companies, navigate the complex requirements to maintain compliance with FDA, QSR, ISO 3485, IVDD/IVDR and other industry regulations, as well as supporting responses to address quality and regulatory deficiencies and providing regulatory due diligence related to mergers and acquisitions.
Since 2009, Karin has held several board member positions, including president, for the Association of Medical Diagnostics Manufacturers (AMDM).
Before joining Beaufort, Karin held key leadership positions:
- Vice President, Clinical and Regulatory Strategy, Astute Medical, Inc. (a BioMérieux subsidiary)
- Director, Regulatory Affairs, Biosite, Inc.
- Director, Product Management, Merck, KGaA
- Vice President, Research & Development, Prolinx, Inc.
Karin holds a B.S. degree in Chemistry from Hartwick College, Oneonta, NY and a Ph.D. in Chemistry from the University of Virginia. She is located in San Diego, CA.